Canada Markets open in 24 mins

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.92-0.06 (-0.55%)
At close: 04:00PM EST
11.40 +0.48 (+4.40%)
Pre-Market: 08:43AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close10.98
Open11.02
Bid11.00 x 1400
Ask11.40 x 1400
Day's Range10.80 - 11.32
52 Week Range10.45 - 22.91
Volume254,002
Avg. Volume448,791
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Motley Fool

    These 4 Psychedelic Biotech Stocks Are Leading the Pack

    Mental illnesses are tough to treat, and researchers are always looking for better ways to pull through for patients. In this vein, novel interventions based on the illicit psychedelic drugs of yesteryear could well become the advanced mental health therapies of tomorrow. Right now, there's a rapidly growing field of biotech companies developing treatments with psychedelics, and there's money to be made for investors who can identify the future winners.

  • Motley Fool

    3 Disruptive Mental Health Stocks to Consider Buying Before They're Huge

    In any sector with entrenched competitors, there's room for a disruptive upstart to come in and steal oodles of market share. Before patients even get to the front door of the therapy clinic, they've interacted with the company's automated online prep platform, which helps them to get ready for their experience.

  • Yahoo Finance Video

    Psychedelics space is just getting started: Field Trip Health Chairman

    Ronan Levy, Field Trip Health Chairman, joins Yahoo Finance to discuss the psychedelic company’s debut on the Nasdaq and the development of the psychedelics.